Tool overview
Scoop is listed under Healthcare AI tools.
What is Scoop?
Scoop is an AI-native regulatory platform for drafting and maintaining Investigational New Drug submissions. It ingests scientific reports, CMC materials, and supporting documents, maps evidence to IND sections, drafts traceable narratives, and flags conflicting or outdated language.
Best for
Biopharma teams drafting and maintaining Investigational New Drug submissions
Who is it for?
Decision note
Potentially valuable for life sciences teams managing complex IND documentation. Require security and validation evidence, data-governance terms, traceability testing, reviewer controls, document-system compatibility, and regulatory sign-off before operational adoption.
Key features
Maps scientific evidence to IND submission sections
Drafts regulatory narratives with source traceability
Flags conflicts and outdated submission language
Maintains documents as underlying data changes
Organizes CMC and supporting technical materials
Use cases
Prepare an initial IND submission draft
Maintain IND content after study updates
Organize CMC evidence across documents
Trace regulatory statements to source materials
Identify inconsistencies before expert review
Pros
- Designed specifically for IND workflows
- Preserves traceability to supporting evidence
- Supports continuous document maintenance
- Surfaces conflicting or stale language for review
Cons
- Commercial pricing is not public
- Regulatory experts must still validate every submission decision
Limitations
Scoop can accelerate drafting and evidence organization, but it does not replace regulatory strategy, scientific judgment, quality assurance, legal review, sponsor accountability, or agency interaction. Generated content must be validated against current data, applicable guidance, and submission requirements.
Pricing details
Pricing note
Scoop does not publish stable self-service pricing and directs prospective customers to contact the company. Pricing Model and Starting Price are recorded as Contact sales. No ongoing free plan or separate free trial was confirmed from official sources.
Supported languages
- English
Please log in to join the discussion.